Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein regulatory complex subunit 2 (DRC2), also known as coiled-coil domain-containing protein 65 (CCDC65), is a protein component of the nexin-dynein regulatory complex (N-DRC), which plays a pivotal role in the regulation of ciliary and flagellar motility. DRC2 forms a structural scaffold with DRC1 to anchor the N-DRC to the A-tubule of axonemal doublet microtubules and mediate interactions with other regulatory structures, including dynein arms and radial spokes. Mutations in DRC2 disrupt the assembly and stability of the N-DRC and related motility complexes, leading to impaired ciliary movement and the clinical syndrome primary ciliary dyskinesia, characterized by chronic respiratory tract infections and other features of dysfunctional motile cilia. DRC2 is not currently considered a therapeutic target or druggable receptor but is important for understanding ciliary biology and related genetic diseases[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein regulatory complex subunit 2 (DRC2).